Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
International Journal of Medicinal Mushrooms
Factor de Impacto: 1.423 Factor de Impacto de 5 años: 1.525 SJR: 0.431 SNIP: 0.716 CiteScore™: 2.6

ISSN Imprimir: 1521-9437
ISSN En Línea: 1940-4344

Volumes:
Volumen 22, 2020 Volumen 21, 2019 Volumen 20, 2018 Volumen 19, 2017 Volumen 18, 2016 Volumen 17, 2015 Volumen 16, 2014 Volumen 15, 2013 Volumen 14, 2012 Volumen 13, 2011 Volumen 12, 2010 Volumen 11, 2009 Volumen 10, 2008 Volumen 9, 2007 Volumen 8, 2006 Volumen 7, 2005 Volumen 6, 2004 Volumen 5, 2003 Volumen 4, 2002 Volumen 3, 2001 Volumen 2, 2000 Volumen 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushr.v7.i12.140
pages 141-146

Potential Role of Medicinal Mushrooms in Breast Cancer Treatment: Current Knowledge and Future Perspectives

Roumyana D. Petrova
Institute of Evolution, University of Haifa, Mount Carmel, Haifa; Migal-Galilee Technology Center, South Industrial Zone, Kiryat Shmona, Israel;Bulgarian Mycological Society, 23 Acad. G. Bonchev St., Sofia 1113, Bulgaria
Solomon P. Wasser
International Centre for Biotechnology and Biodiversity of Fungi Institute of Evolution and Faculty of Natural Sciences University of Haifa, Mt. Carmel, Haifa 31905, Israel
Jamal A. Mahajna
Migal, Galilee Technology Center, Cancer Drug Discovery Program, Kiryat Shmona; Galilee Institute for Applied Research, Nazareth
Cvetomir M. Denchev
Institute of Botany, Bulgarian Academy of Sciences, Sofia, Bulgaria
Eviatar D. Nevo
Department of Evolutionary and Environmental Biology, Faculty of Natural Sciences, Institute of Evolution, University of Haifa, 199 Abba Khousi Ave., Mt. Carmel, Haifa 3498838, Israel

SINOPSIS

Breast cancer has become the most common invasive form of female cancer in the last few decades. Statistics show that the rate of newly diagnosed cases of breast cancer is rising every year depending on age, race, heredity, and ethnicity. The National Cancer Institute of US and mainly the Division of Cancer Control and Population Sciences (DCCPS) promote and conduct research that also identifies the economic, social, cultural, psychological, behavioral, and biological mechanisms that are potential reasons for breast cancer development. Advanced breast cancers do not respond well to therapy, and their gene expression arouses uncontrolled growth. Although estrogen-receptor (ER)-positive breast cancers respond to hormonal therapy, the treatment of ER-negative cancers is more complicated because of their ability for developing resistance to drugs. Lack of molecular targets in estrogen receptor-negative breast cancer is a major therapeutic hurdle. It has been known that NF-κB is significantly important in the processes of inflammation, cell survival, transformation, and oncogenesis, as well as in the etiology of breast cancer. A theory exists, according to which ER-negative breast cancer cells depend on NF-κB for aberrant cell proliferation and simultaneously avoid apoptosis, suggesting that NF-κB can be used as a potential molecular target in breast cancer treatment. Studies on new anticancer treatments and other medicinal substances from mushrooms have been significantly expanded in the last few years. This is mainly because they contain bioactive polymers such as polysaccharides and polysaccharide/protein complexes, secondary metabolites, and enzymes isolated from fruit bodies, mycelia, and culture broth. There are data showing the potential activity of medicinal mushrooms in breast cancer treatment. Ganoderma lucidum has shown the most significant inhibitory effect on NF-κB activity in highly invasive breast cancer cells. Other medicinal mushrooms that have also been reported to produce biologically active substances, have been tested in in vivo or in vitro, and have demonstrated breast cancer inhibitory activity are Agaricus bisporus, A. brasiliensis, Trametes versicolor, Grifola frondosa, Inonotus obliquus, Lentinus edodes, Leucoagaricus americanus, Pleurotus ostreatus, Sparassis crispa, etc.


Articles with similar content:

New Scientific Approaches to Cancer Treatment: Can Medicinal Mushrooms Defeat the Curse of the Century?
International Journal of Medicinal Mushrooms, Vol.14, 2012, issue 1
Roumyana D. Petrova
Therapeutic Effects of Substances Occurring in Higher Basidiomycetes Mushrooms: A Modern Perspective
Critical Reviews™ in Immunology, Vol.19, 1999, issue 1
Solomon P. Wasser, Alexander L. Weis
The Key Role of Mitochondrial Apoptotic Pathway in the Cytotoxic Effect of Mushroom Extracts on Cancer Cells
Critical Reviews™ in Eukaryotic Gene Expression, Vol.25, 2015, issue 3
Jiezhong Chen, Mei Han, Ming-Tat Ling
Medicinal Value of Turkey Tail Fungus Trametes versicolor (L.:Fr.) Pilat (Aphyllophoromycetideae)
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 3
Christopher Hobbs
A Review of Pharmacological Activities of Mushroom Polysaccharides
International Journal of Medicinal Mushrooms, Vol.1, 1999, issue 3
Vincent Eng Choo Ooi, Fang Liu